Trade Arcus Biosciences, Inc. - RCUS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.32 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 15.8 |
| Open | 15.62 |
| 1-Year Change | -13.84% |
| Day's Range | 15.38 - 15.85 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 24, 2024 | 15.79 | 0.32 | 2.07% | 15.47 | 15.88 | 15.36 |
| Dec 23, 2024 | 15.78 | 0.52 | 3.41% | 15.26 | 15.91 | 15.20 |
| Dec 20, 2024 | 15.45 | 0.45 | 3.00% | 15.00 | 15.90 | 14.99 |
| Dec 19, 2024 | 15.42 | 0.43 | 2.87% | 14.99 | 15.67 | 14.66 |
| Dec 18, 2024 | 14.78 | -1.02 | -6.46% | 15.80 | 16.22 | 14.78 |
| Dec 17, 2024 | 16.02 | 0.09 | 0.56% | 15.93 | 16.35 | 15.72 |
| Dec 16, 2024 | 16.44 | 0.61 | 3.85% | 15.83 | 16.49 | 15.55 |
| Dec 13, 2024 | 15.97 | -0.63 | -3.80% | 16.60 | 17.12 | 15.89 |
| Dec 12, 2024 | 17.06 | -0.42 | -2.40% | 17.48 | 17.62 | 16.92 |
| Dec 11, 2024 | 17.92 | 0.80 | 4.67% | 17.12 | 18.01 | 16.92 |
| Dec 10, 2024 | 17.26 | 0.33 | 1.95% | 16.93 | 17.59 | 16.76 |
| Dec 9, 2024 | 17.35 | 0.08 | 0.46% | 17.27 | 17.86 | 17.17 |
| Dec 6, 2024 | 17.10 | 0.14 | 0.83% | 16.96 | 18.02 | 16.86 |
| Dec 5, 2024 | 16.97 | 0.31 | 1.86% | 16.66 | 17.65 | 16.48 |
| Dec 4, 2024 | 17.00 | 0.96 | 5.99% | 16.04 | 17.33 | 15.99 |
| Dec 3, 2024 | 16.42 | 0.71 | 4.52% | 15.71 | 16.53 | 15.61 |
| Dec 2, 2024 | 15.85 | 0.77 | 5.11% | 15.08 | 15.99 | 15.01 |
| Nov 29, 2024 | 15.32 | -0.15 | -0.97% | 15.47 | 15.77 | 15.30 |
| Nov 27, 2024 | 15.67 | -0.14 | -0.89% | 15.81 | 16.18 | 15.48 |
| Nov 26, 2024 | 15.75 | 1.72 | 12.26% | 14.03 | 16.43 | 14.03 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Arcus Biosciences, Inc. Company profile
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer therapies in the United States. The company''s product pipeline includes, AB928, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 monoclonal antibody that is in Phase Ib clinical trial for monotherapy. It is also developing AB154, an anti-TIGIT monoclonal antibody, which is in Phase 2 development for the treatment of first-line metastatic non-small cell lung cancer in combination with Zimberelimab and AB928; and AB680, small-molecule CD73 inhibitor is in a Phase 1/1b study for the treatment of first-line metastatic pancreatic cancer. Arcus Biosciences, Inc. has a clinical development collaboration agreement with Strata Oncology, Inc. to evaluate Zimberelimab; license agreements with Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC, and WuXi Biologics (Cayman) Inc.; and co-development and co-commercialization partnership with Gilead Sciences, Inc. for the development of cancer immunotherapies. The company was founded in 2015 and is based in Hayward, California.| Industry: | Biotechnology & Medical Research (NEC) |
3928 Point Eden Way
HAYWARD
CALIFORNIA 94545-3719
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com